News
Market Information


Burger-flipper to tech unicorn: Australia’s newest billionaire

How Access to Private Capital is far easier now - no need to IPO
Four years ago, when Afterpay (ASX.APT) listed on the ASX its Board of Directors had to weigh up the pro’s and con’s for IPOing. In reality, at that time, access to private capital was limited and much harder to access than it is today. Read more.

Is Private the New Public?
Private Company Share Trading on a Global Platform- the New Black Read more.

Genex kick-starts Kidston wind project, securing partnership with J-Power
Genex plans to build a 150MW wind farm at the site of its Kidston energy hub in North Queensland, as part of a substantial portfolio of clean energy projects clustered around the 250MW/2,000MWh Kidston pumped hydro energy storage project, which is utilising two disused gold mine pits to store water for energy storage. Read more.

What is a Private Trading Hub?
A Private Trading Hub is a dedicated platform that enables investors and shareholders to buy and sell shares in private/ unlisted companies. In other words, it works in a similar way as the share market does for publicly listed companies. Read more.

Investing in private, high-value companies is now more attainable
Secondary Trading is where investors buy or sell (trade) shares (securities) in private/ unlisted companies. This trading differs from a stock exchange in that the secondary market deals with private unlisted companies rather than publicly listed ones. Read more.

Who are PrimaryMarkets?
PrimaryMarkets provides a global trading platform to buy and sell shares in unlisted companies. Buyers are able to source unique, tightly held investment opportunities and purchase global share investments in a secure, controlled environment. Read more.

$500m Derwent Valley project a step closer as developer lodges council plans
The developers behind a $500 million residential and community precinct in Tasmania's Derwent Valley have put their first plans to council and expect to have all applications lodged by the end of the year. Read more.

Why the Pharmaxis (ASX:PXS) share price has rocketed up 48%
Pharmaxis Ltd (ASX: PXS) today published a quarterly update in which the company reported three significant events. Consequently, the Pharmaxis share price has shot up 47.73% to 13 cents this morning. The pharmaceutical research company is working on inflammation and fibrosis. In addition it already has a portfolio of products at various stages of development and approval. Read more.
Recent Posts
- To List or Not To List?
- Burger-flipper to tech unicorn: Australia’s newest billionaire
- How Access to Private Capital is far easier now - no need to IPO
- Is Private the New Public?
- Genex kick-starts Kidston wind project, securing partnership with J-Power
- What is a Private Trading Hub?
- Investing in private, high-value companies is now more attainable
- Who are PrimaryMarkets?
- $500m Derwent Valley project a step closer as developer lodges council plans
- Why the Pharmaxis (ASX:PXS) share price has rocketed up 48%